Find a Conference

Alert - GRC systems are offline for approximately one week. For more information, please click here.

Preclinical Form and Formulation for Drug Discovery (GRS)

Gordon Research Seminar

Leveraging Advanced Characterization Methods and Novel Delivery Systems for Preclinical Drug Formulation

June 8 - 9, 2019
Chairs Ashley Lay-Fortenbery and Adriana-Michelle Wolf Pérez
Waterville Valley
56 Packard's Road
Waterville Valley, New Hampshire, United States
 Venue and Travel Information

Conference Description

The Gordon Research Seminar (GRS) on Preclinical Form and Formulation for Drug Discovery brings together the future of our field to discuss and share ideas on how to address challenges in drug development. It is a unique opportunity for young scientists, including graduate students, post-docs, and other early career scientists, to present unpublished cutting-edge research and to exchange ideas and experiences leading to new collaborations as well as career development.

The focus of this GRS is on innovative drug development techniques for both small molecules and large molecules (proteins, genes, and peptides). Topics of interest include, but are not limited to, leveraging advanced formulation characterization tools to predict drug stability and the development of novel drug delivery systems. Additionally, experts in academia and industry will share their experience and provide a general perspective on the future of pharmaceutical research.

Related Meeting

This GRS will be held in conjunction with the "Preclinical Form and Formulation for Drug Discovery" Gordon Research Conference (GRC). Those interested in attending both meetings must submit an application for the GRC in addition to an application for the GRS. Refer to the associated GRC program page for more information.

Conference Program

Saturday
2:00 pm - 5:00 pm
Arrival and Check-in
3:30 pm - 3:45 pm
Introductory Comments by GRC Site Staff / Welcome from the GRS Chair
3:45 pm - 4:30 pm
Keynote Session: Pharmaceutical Development of Emerging Therapeutic Classes
Discussion Leader: Elizabeth Topp (Purdue University, USA)
3:45 pm - 4:20 pm
Frank Tagliaferri (Wolfe Laboratories, USA)
"Pharmaceutical Development of Oligonucleotides, an Emerging Therapeutic Class"
4:20 pm - 4:30 pm
Discussion
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 7:00 pm
Dinner
7:30 pm - 9:30 pm
Advanced Formulation Characterization Tools
Discussion Leaders: Yongchao Su (Merck & Co., Inc., USA) and Haichen Nie (AbbVie Inc., USA)
7:30 pm - 7:50 pm
Anuradha Wijesekara (Iowa State University, USA)
"Rapid Characterization of Formulated Pharmaceuticals Using Fast MAS 1H Solid State NMR Spectroscopy"
7:50 pm - 8:00 pm
Discussion
8:00 pm - 8:20 pm
Nathan Wilson (Purdue University, USA)
"Effects of Processing Method and Excipient on Protein Structure and Stability Using Solid-State Hydrogen/Deuterium Exchange Mass Spectrometry"
8:20 pm - 8:30 pm
Discussion
8:30 pm - 8:50 pm
Kweku Amponsah-Efah (University of Minnesota, USA)
"Advanced Characterization Methods for Drug-Polymer Complexes in Aqueous Solution"
8:50 pm - 9:00 pm
Discussion
9:00 pm - 9:20 pm
Patrick Sinko (University of Michigan, USA)
"Characterization and Application of an Ultra Thin Large Area Polydimethylsiloxane Membrane for In Vivo Relevant Dissolution Methodologies"
9:20 pm - 9:30 pm
Discussion
Sunday
7:30 am - 8:30 am
Breakfast
9:00 am - 11:00 am
Novel Drug Delivery Systems
Discussion Leaders: Sandro Matosevic (Purdue University, USA) and Anand Gupta (University of Connecticut, USA)
9:00 am - 9:20 am
Anshul Dhankher (Georgia Institute of Technology, USA)
"Structural Characterization of a Drug Carrier for Intracellular Antibody Delivery"
9:20 am - 9:30 am
Discussion
9:30 am - 9:50 am
Kalpeshkumar Giri (Macquarie University, Australia)
"Towards Understanding the Effect of the Protein Corona on Drug Release from Different Mesoporous Silica Particles"
9:50 am - 10:00 am
Discussion
10:00 am - 10:20 am
Shipra Malik (University of Connecticut, USA)
"Next Generation PNAs Targeting OncomiRs for Cancer Therapy"
10:20 am - 10:30 am
Discussion
10:30 am - 10:50 am
Yihua Pei (Purdue University, USA)
"pH-Responsive Nanoantibiotics for Combating Intracellular Superbugs"
10:50 am - 11:00 am
Discussion
11:00 am - 12:30 pm
Poster Session
Coffee will be served in the poster area from 11:00 am - 11:30 am
12:30 pm - 1:30 pm
Lunch
1:30 pm - 2:30 pm
Mentorship Component: Career Panel
Discussion Leader: Annette Bak (AstraZeneca, Sweden)
1:30 pm - 2:30 pm
Panel Discussion
Navigating a Career in Pharmaceutical Sciences
  • Julie Champion (Georgia Institute of Technology, USA)
  • Sachin Lohani (Celgene, USA)
  • Haichen Nie (AbbVie Inc., USA)
2:30 pm - 3:00 pm
Evaluation Period
Fill in GRS Evaluation Forms
3:00 pm
Seminar Concludes

Contributors

National Institutes of Health
Merck & Co., Inc.
Liquidia Technologies
Genentech, Inc.
GlaxoSmithKline

Research reported in this publication was supported by the National Center For Advancing Translational Sciences of the National Institutes of Health under Award Number R13TR002723. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Conference Links

Conference History Preclinical Form and Formulation for Drug Discovery
Additional Fee Info

Preclinical Form and Formulation for Drug Discovery
June 22 - 27, 2025


Contact Us

MyGRC Account
Check your application status, complete your registration, update your poster, change your rooming preference, make a bus reservation, print an invitation letter, print a receipt (which includes verification that you are presenting a poster) or print an invoice by logging into your account.

GRC Venues
Everything you need to know, to plan your trip.

FAQs
Instant answers to common questions.

Tell us how we can help

Call us and leave a detailed message at: 401-783-4011

*This voicemail is only checked once daily. Due to high volume of requests during the conference season, responses may be delayed.

You have no notifications